[ad_1]
The WHO, whose advisory committee is reviewing available data on the safety of the vaccine, stressed that a causal relationship between the vaccine and increased blood clotting has not been established.
The UN health agency has also indicated that more than 260 million doses of this coronavirus vaccine have not been associated with deaths associated with COVID-19.
Denmark, Norway and Iceland have prevented the use of AstraZeneca as a precautionary measure following individual reports of blood clots in patients who have received it.
Italy and Austria have banned vaccination with certain batches of AstraZeneca, while Thailand and Bulgaria have indicated that they are blocking distribution of the vaccine for the time being.
However, a whole chain of global health authorities, including the European Medicines Agency and WHO, claim that the vaccine is safe.
“AstraZeneca is a great vaccine, just like any other vaccine in use,” WHO spokeswoman Margaret Harris told reporters in Geneva.
“Yes, we must continue to use the AstraZeneca vaccine,” he added, emphasizing that any safety concerns must be addressed.
“We must always make sure to look for safety signs when distributing vaccines, and we must review them,” he said. “But there are no directions not to use them.”
VAS: severe allergies should be included in the list of side effects
Severe allergies should be included on AstraZeneca’s list of potential COVID-19 vaccine side effects, with a likely link between such cases and vaccination in the UK, the European Medicines Agency said on Friday.
The day before, the European Medicines Agency (EMA) announced that it was conducting a separate study on blood clots, prompting Denmark to stop using the vaccine, but assured it that the vaccine was safe.
On Friday, the EEA said it “recommended updating the information on this product to include anaphylaxis and hypersensitivity (allergic reactions) as side effects.”
“The update is based on 41 reports of possible cases of anaphylaxis observed in approximately 5 million patients. Vaccination in the UK,” says a report from the EEA Drug Risk Assessment Committee.
“After careful review of these data,[el comité]concluded that at least some of these cases may be related to the vaccine, “he said.
However, the EVA noted that anaphylaxis, also known as “sudden allergic reaction,” was already included in “known very rare side effects.”
The AstraZeneca product insert has previously advised that people should be “closely monitored for at least 15 minutes after vaccination for possible allergic reactions.”
It is not allowed to publish, quote or reproduce the information of the BNS news agency in the media and on websites without the written consent of the UAB “BNS”.
[ad_2]
